Highlights
- Market Cap
- £43.40M
- Enterprise Value
- £34.82M
- EPS (TTM)
- £0.03
- PE Ratio
- 1.91
- PEG Ratio
- 0.00
- Total Revenue (TTM)
- £118.19M
- Gross Profit (TTM)
- £73.57M
- EBITDA (TTM)
- £27.67M
- Year Range
- £0.04 - £0.20
- ROA (TTM)
- 26.53%
- ROE (TTM)
- 52.10%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in hVIVO PLC, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Different Benchmark Currency
HVO.L is traded in GBp, while the ^GSPC benchmark is in USD. To make them comparable, the benchmark values have been converted to GBp using the latest available exchange rates.
Returns By Period
hVIVO PLC (HVO.L) has returned 0.00% so far this year and -52.45% over the past 12 months. Over the last ten years, HVO.L has returned -11.45% per year, falling short of the S&P 500 Index benchmark, which averaged 12.98% annually.
hVIVO PLC
- 1D
- 1.94%
- 1M
- -25.88%
- YTD
- 0.00%
- 6M
- -19.23%
- 1Y
- -52.45%
- 3Y*
- -23.26%
- 5Y*
- -27.74%
- 10Y*
- -11.45%
Benchmark (S&P 500 Index)
- 1D
- 2.61%
- 1M
- -3.22%
- YTD
- -2.82%
- 6M
- -0.72%
- 1Y
- 13.66%
- 3Y*
- 14.01%
- 5Y*
- 11.18%
- 10Y*
- 12.98%
Monthly Returns
Based on dividend-adjusted daily data since Dec 14, 2012, HVO.L's average daily return is +0.03%, while the average monthly return is +0.92%. At this rate, your investment would double in approximately 6.3 years.
Historically, 41% of months were positive and 59% were negative. The best month was Jun 2019 with a return of +156.6%, while the worst month was May 2025 at -53.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.
On a daily basis, HVO.L closed higher 27% of trading days. The best single day was Jun 11, 2019 with a return of +88.7%, while the worst single day was May 30, 2025 at -46.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.76% | 41.67% | -25.88% | 0.00% | |||||||||
| 2025 | -6.10% | -14.29% | -18.79% | 42.54% | -53.93% | 26.44% | -6.82% | -3.41% | -21.21% | -15.64% | -13.98% | 11.31% | -68.92% |
| 2024 | 23.37% | -13.99% | 17.06% | -3.71% | -4.96% | 0.56% | 10.39% | -1.18% | -4.08% | 1.06% | -23.68% | -5.75% | -13.05% |
| 2023 | 70.00% | 20.59% | -28.78% | 10.10% | 0.73% | -7.30% | 14.73% | 8.96% | 10.68% | -4.70% | 8.05% | 14.18% | 144.16% |
| 2022 | -19.57% | -25.68% | 5.45% | 0.00% | 1.72% | -20.34% | -9.79% | -1.42% | -1.91% | -1.95% | 23.38% | -19.35% | -56.52% |
| 2021 | -10.85% | 25.00% | 18.26% | 22.79% | -10.18% | -21.07% | -21.28% | 13.73% | -19.81% | -5.88% | -8.70% | 25.96% | -10.85% |
Benchmark Metrics
hVIVO PLC has an annualized alpha of 11.03%, beta of 0.03, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since December 18, 2012.
- This stock participated in 126.90% of S&P 500 Index downside but only 29.89% of its upside — more exposed to losses than it benefited from rallies.
- Beta of 0.03 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 11.03%
- Beta
- 0.03
- R²
- 0.00
- Upside Capture
- 29.89%
- Downside Capture
- 126.90%
Return for Risk
Risk / Return Rank
HVO.L ranks 18 for risk / return — in the bottom 18% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for hVIVO PLC (HVO.L) and compare them to a chosen benchmark (S&P 500 Index).
| HVO.L | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.62 | 0.73 | -1.35 |
Sortino ratioReturn per unit of downside risk | -0.58 | 1.14 | -1.72 |
Omega ratioGain probability vs. loss probability | 0.91 | 1.18 | -0.27 |
Calmar ratioReturn relative to maximum drawdown | -0.67 | 1.24 | -1.91 |
Martin ratioReturn relative to average drawdown | -0.96 | 4.87 | -5.82 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore HVO.L risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
hVIVO PLC provided a 3.17% dividend yield over the last twelve months, with an annual payout of £0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Dividend | £0.00 | £0.00 | £0.00 | £0.00 |
Dividend yield | 3.17% | 3.17% | 0.98% | 1.89% |
Monthly Dividends
The table displays the monthly dividend distributions for hVIVO PLC. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | £0.00 | £0.00 | £0.00 | £0.00 | |||||||||
| 2025 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| 2024 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| 2023 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Dividend Yield & Payout
Dividend Yield
hVIVO PLC has a dividend yield of 3.17%, which is quite average when compared to the overall market.
Payout Ratio
hVIVO PLC has a payout ratio of 25.45%, which is below the market average. This means hVIVO PLC returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the hVIVO PLC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the hVIVO PLC was 95.72%, occurring on Jan 21, 2019. Recovery took 539 trading sessions.
The current hVIVO PLC drawdown is 85.34%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.72% | Jan 7, 2013 | 1491 | Jan 21, 2019 | 539 | Apr 7, 2021 | 2030 |
| -89.32% | Apr 13, 2021 | 1179 | Dec 10, 2025 | — | — | — |
| -14.29% | Dec 18, 2012 | 2 | Dec 19, 2012 | 6 | Dec 31, 2012 | 8 |
| -10.61% | Jan 2, 2013 | 1 | Jan 2, 2013 | 1 | Jan 4, 2013 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of hVIVO PLC over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how hVIVO PLC is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for HVO.L, comparing it with other companies in the Biotechnology industry. Currently, HVO.L has a P/E ratio of 1.9. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for HVO.L compared to other companies in the Biotechnology industry. HVO.L currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HVO.L relative to other companies in the Biotechnology industry. Currently, HVO.L has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HVO.L in comparison with other companies in the Biotechnology industry. Currently, HVO.L has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |